Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Emma Birks
Added:
1 year ago
Optimum Therapies for ST-Elevation Myocardial Infarction Managed with Primary Percutaneous Coronary…
Author(s):
Bruce R Brodie
Added:
3 years ago
Article
Author(s):
Subbarao Myla
,
Sepideh Kazemi
Added:
3 years ago
Insights from Carotid Artery Stenting Registries
Registries tend to have less stringent inclusion and exclusion criteria than randomised trials and provide real-world data on a broad variety of patients treated by a range of interventionists of varying experience. Registries serve to provide first-time evaluation of new devices, help set up learning curve pearls, can be hypothesis-generating and…
View more
Author(s):
Eugene Braunwald
Added:
6 years ago
Author(s):
Jason N Katz
,
Sunil V Rao
Added:
3 years ago
There has been a significant evolution in the management of patients with acute coronary syndromes (ACS), largely driven by advances in pharmacological therapy. Increased implementation of evidence-based antithrombotics and antiplatelet agents has led to improved patient outcomes.1,2 Additionally, management algorithms favouring early invasive intervention in high-risk patients are gaining…
View more
Author(s):
Tom Ford
,
Colin Berry
Added:
3 years ago
Ischaemic heart disease persists as the leading global cause of death and lost life years in adults.1 Angina is a common clinical presentation of ischaemic heart disease related to a supply:demand mismatch of myocardial blood flow, typically provoked by exertion or stress. Invasive coronary angiography is the reference test for angina and identifies obstructive coronary artery disease (CAD) as a…
View more
Author(s):
Constantinos O’Mahony
,
Saidi Mohiddin
,
Charles Knight
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of cardiac muscle with a heterogeneous clinical course.1 The disease is clinically characterised by left ventricular hypertrophy (LVH), which is typically asymmetric, and a subgroup of patients have left ventricular outflow tract obstruction (LVOTO) caused by systolic anterior motion (SAM) of the mitral valve leaflet(s).2,3 LVOTO is often…
View more
Author(s):
Henry Seligman
,
Sayan Sen
,
Sukhjinder Nijjer
,
et al
Added:
3 years ago
International guidelines provide clinicians with evidence-based recommendations on how to manage patients presenting with acute coronary syndromes (ACS). Guidance includes the appropriateness and optimal timing for percutaneous interventions as well as the ideal length of hospital stay.1–5 However, the current global pandemic of coronavirus disease 2019 (COVID-19), has posed an unprecedented…
View more
Author(s):
Dagmar M Ouweneel
,
Bimmer E Claessen
,
Krischan D Sjauw
,
et al
Added:
3 years ago
The main goal of mechanical cardiac assistance is to provide haemodynamic support in case of an endangered coronary or systemic circulation by increasing or maintaining coronary and systemic blood flow. In addition to haemodynamic support, mechanical cardiac assistance may also provide myocardial protection by unloading the ventricle. The experience with percutaneous mechanical support devices is…
View more